These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 23849590)

  • 1. Australian population trends and disparities in cholinesterase inhibitor use, 2003 to 2010.
    Zilkens RR; Duke J; Horner B; Semmens JB; Bruce DG
    Alzheimers Dement; 2014 May; 10(3):310-8. PubMed ID: 23849590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gender, socioeconomic status, need or access? Differences in statin prescribing across urban, rural and remote Australia.
    Stocks N; Ryan P; Allan J; Williams S; Willson K
    Aust J Rural Health; 2009 Apr; 17(2):92-6. PubMed ID: 19335599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antidementia drug prescription sources and patterns after the diagnosis of dementia in Germany: results of a claims data-based 1-year follow-up.
    van den Bussche H; Kaduszkiewicz H; Koller D; Eisele M; Steinmann S; Glaeske G; Wiese B
    Int Clin Psychopharmacol; 2011 Jul; 26(4):225-31. PubMed ID: 21394033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in utilisation of anticholinergic drugs after initiation of cholinesterase inhibitors.
    Robinson M; Rowett D; Leverton A; Mabbott V
    Pharmacoepidemiol Drug Saf; 2009 Aug; 18(8):659-64. PubMed ID: 19548222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statin prescribing in Australia: socioeconomic and sex differences. A cross-sectional study.
    Stocks NP; Ryan P; McElroy H; Allan J
    Med J Aust; 2004 Mar; 180(5):229-31. PubMed ID: 14984343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prescribing trends in cognition enhancing drugs in Australia.
    Hollingworth SA; Byrne GJ
    Int Psychogeriatr; 2011 Mar; 23(2):238-45. PubMed ID: 20670461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association of socioeconomic disadvantage and remoteness with receipt of type 2 diabetes medications in Australia: a nationwide registry study.
    Morton JI; Ilomӓki J; Magliano DJ; Shaw JE
    Diabetologia; 2021 Feb; 64(2):349-360. PubMed ID: 33078206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eight-year prescription trends of memantine and cholinesterase inhibitors among persons 65 years and older in Germany.
    Hoffmann F; van den Bussche H; Glaeske G; Kaduszkiewicz H
    Int Clin Psychopharmacol; 2010 Jan; 25(1):29-36. PubMed ID: 19934763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistence with cholinesterase inhibitor therapy in a population-based cohort of patients with Alzheimer's disease.
    Amuah JE; Hogan DB; Eliasziw M; Supina A; Beck P; Downey W; Maxwell CJ
    Pharmacoepidemiol Drug Saf; 2010 Jul; 19(7):670-9. PubMed ID: 20583207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lower Barthel Index scores predict less prescription of pharmacological therapy in elderly patients with Alzheimer disease.
    Formiga F; Fort I; Robles MJ; Rodriguez D; Regalado P
    Dement Geriatr Cogn Disord; 2010; 29(3):198-203. PubMed ID: 20332637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Geographic modelling of jaw fracture rates in Australia: a methodological model for healthcare planning.
    Kruger E; Heitz-Mayfield LJ; Perera I; Tennant M
    Dent Traumatol; 2010 Jun; 26(3):217-22. PubMed ID: 20572838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of drug treatments for Alzheimer's disease in France: a study on a national level based on the National Alzheimer's Data Bank (Banque Nationale Alzheimer).
    Tifratene K; Duff FL; Pradier C; Quetel J; Lafay P; Schück S; Benzenine E; Quantin C; Robert P
    Pharmacoepidemiol Drug Saf; 2012 Sep; 21(9):1005-12. PubMed ID: 22718684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rural-urban disparities in the management and health issues of chronic diseases in Quebec (Canada) in the early 2000s.
    Vanasse A; Courteau J; Cohen AA; Orzanco MG; Drouin C
    Rural Remote Health; 2010; 10(4):1548. PubMed ID: 21039080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adherence, persistence and continuation with cholinesterase inhibitors in Alzheimer's disease.
    Le Couteur DG; Robinson M; Leverton A; Creasey H; Waite L; Atkins K; McLachlan AJ
    Australas J Ageing; 2012 Sep; 31(3):164-9. PubMed ID: 22950587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variability in the prescription of cholinesterase inhibitors and memantine.
    Villar-Fernández I; Bjerrum L; Feja C; Rabanaque MJ
    Dement Geriatr Cogn Disord; 2009; 28(4):373-9. PubMed ID: 19887800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Alzheimer's disease therapy--theory and practice].
    Gabryelewicz T; Barcikowska M; Jarczewska DL
    Wiad Lek; 2005; 58(9-10):528-35. PubMed ID: 16529064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug prescription in mild cognitive impairment: the physicians' perspective in Italy.
    Frisoni GB; Canu E; Geroldi C; Zanetti O; Zacchi V
    Int J Geriatr Psychiatry; 2006 Nov; 21(11):1071-7. PubMed ID: 16955446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Temporal trends in clomiphene citrate use: a population-based study.
    Lisonkova S; Joseph KS
    Fertil Steril; 2012 Mar; 97(3):639-44. PubMed ID: 22270554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disparities in the access to primary healthcare in rural areas from the county of Iasi - Romania.
    Duma OO; Roşu ST; Manole M; Petrariu FD; Constantin B
    Rev Med Chir Soc Med Nat Iasi; 2014; 118(3):743-8. PubMed ID: 25341295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A population view of mental illness in South Australia: broader issues than location.
    Eckert KA; Wilkinson D; Taylor AW; Stewart S; Tucker GR
    Rural Remote Health; 2006; 6(2):541. PubMed ID: 16774455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.